Suppr超能文献

乳铁蛋白在骨质减少和骨质疏松症中的作用。

Role of lactoferrin in osteopenia and osteoporosis.

作者信息

Li Deming, Gao Maofeng, Li Meng, Zhao Huan, Zhou Xichao, Gu Qiaoli, Yang Huilin, Shi Qin

机构信息

Department of Orthopedics, The First Affiliated Hospital of Soochow University, Orthopedic Institute of Soochow University, Suzhou Medical College of Soochow University, Suzhou, Jiangsu, China.

出版信息

Front Nutr. 2025 Sep 3;12:1648510. doi: 10.3389/fnut.2025.1648510. eCollection 2025.

Abstract

Osteopenia and osteoporosis (OP) are serious public health concerns that impose substantial health and economic burdens on the global population. Lactoferrin (Lf) is a natural iron-binding glycoprotein that exhibits numerous biological functions. This review summarized the role of circulating Lf and related biomarkers in maintaining bone health. Lf may protect against OP through various mechanisms, including the osteoprotegerin/receptor activator of nuclear factor κB ligand/receptor activator of nuclear factor κB, bone morphogenetic protein signaling pathway, liver-bone axis, insulin-like growth factor 1 signaling pathway, autophagy, and gut microbiota. Moreover, the peptides derived from Lf and Lf-based nanoformulations or biomaterials show potential in preventing OP. Overall, this review supports the potential application of Lf for OP.

摘要

骨量减少和骨质疏松症(OP)是严重的公共卫生问题,给全球人口带来了巨大的健康和经济负担。乳铁蛋白(Lf)是一种天然的铁结合糖蛋白,具有多种生物学功能。本综述总结了循环Lf及相关生物标志物在维持骨骼健康中的作用。Lf可能通过多种机制预防OP,包括骨保护素/核因子κB配体受体激活剂/核因子κB受体激活剂、骨形态发生蛋白信号通路、肝-骨轴、胰岛素样生长因子1信号通路、自噬和肠道微生物群。此外,源自Lf的肽以及基于Lf的纳米制剂或生物材料在预防OP方面显示出潜力。总体而言,本综述支持Lf在OP治疗中的潜在应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8104/12440965/1a58bddd38d8/fnut-12-1648510-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验